These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 29575835)

  • 21. TOA02, a recombinant adenovirus with tumor-specific granulocyte macrophage colony-stimulating factor expression, has limited biodistribution and low toxicity in rhesus monkeys.
    Wang L; Zheng J; He Q; Yu X; Hu X; Deng S; Chang S; Shen F
    Hum Gene Ther Methods; 2015 Apr; 26(2):62-70. PubMed ID: 25763606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
    Varghese S; Rabkin SD; Liu R; Nielsen PG; Ipe T; Martuza RL
    Cancer Gene Ther; 2006 Mar; 13(3):253-65. PubMed ID: 16179929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model.
    Bao L; Haque A; Jackson K; Hazari S; Moroz K; Jetly R; Dash S
    Am J Pathol; 2011 Feb; 178(2):838-52. PubMed ID: 21281816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.
    Le Cesne A; Judson I; Crowther D; Rodenhuis S; Keizer HJ; Van Hoesel Q; Blay JY; Frisch J; Van Glabbeke M; Hermans C; Van Oosterom A; Tursz T; Verweij J
    J Clin Oncol; 2000 Jul; 18(14):2676-84. PubMed ID: 10894866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombopoiesis-stimulating factor: its effects on megakaryocyte colony formation in vitro and its relation to human granulocyte-macrophage colony-stimulating factor.
    Dessypris EN; Chuncharunee S; Frierson KE
    Exp Hematol; 1990 Aug; 18(7):754-7. PubMed ID: 2199204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular endothelial growth factor secreted by breast cancer cells plays a critical role in the formation of pre-metastatic niche in the mouse lung].
    Li R; Yuan B; Zhang Y; Dai J; Zhang P; Fang F; Han M
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):17-22. PubMed ID: 26796801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Replication and expression of oncolytic herpes simplex virus type Ⅱ in tumors].
    Cai Q; Zhang S; Liu H; Liu B
    Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):585-595. PubMed ID: 38369843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of streptavidin-tagged human-granulocyte macrophage colony-stimulating factor fusion proteins.
    Bai L; Hu Z; Wang F; Xu X; Xia C; Jin L; Li J; Gao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Oct; 32(10):1389-93. PubMed ID: 23076170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EB virus-positive tumors are inhibited by rBCG expressing hGM-CSF and LMP2A.
    Yan Y; Xue QJ; Liu A; Wang H; Zhang H; Wang S; Zhao L; Li Y; Li X; Yang Y; Chen T; Li S
    Hum Vaccin Immunother; 2020 Mar; 16(3):654-663. PubMed ID: 31567046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of three forms of differently glycosylated recombinant human granulocyte-macrophage colony-stimulating factor.
    Okamoto M; Nakai M; Nakayama C; Yanagi H; Matsui H; Noguchi H; Namiki M; Sakai J; Kadota K; Fukui M
    Arch Biochem Biophys; 1991 May; 286(2):562-8. PubMed ID: 1897978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.
    Nigim F; Esaki S; Hood M; Lelic N; James MF; Ramesh V; Stemmer-Rachamimov A; Cahill DP; Brastianos PK; Rabkin SD; Martuza RL; Wakimoto H
    Neuro Oncol; 2016 Sep; 18(9):1278-87. PubMed ID: 26951380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53.
    Lebedeva S; Bagdasarova S; Tyler T; Mu X; Wilson DR; Gjerset RA
    Hum Gene Ther; 2001 May; 12(7):763-72. PubMed ID: 11339893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: Anticancer and hepatoprotective effects of atranorin in vivo.
    Solár P; Hrčková G; Koptašíková L; Velebný S; Solárová Z; Bačkor M
    Chem Biol Interact; 2016 Apr; 250():27-37. PubMed ID: 26969521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity.
    Sakamoto C; Kohara H; Inoue H; Narusawa M; Ogawa Y; Hirose-Yotsuya L; Miyamoto S; Matsumura Y; Yamada K; Takahashi A; Tani K
    Cancer Gene Ther; 2017 Apr; 24(4):165-174. PubMed ID: 28084317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the human granulocyte-macrophage colony stimulating factor (hGM-CSF) gene under control of the 5'-regulatory sequence of the goat alpha-S1-casein gene with and without a MAR element in transgenic mice.
    Burkov IA; Serova IA; Battulin NR; Smirnov AV; Babkin IV; Andreeva LE; Dvoryanchikov GA; Serov OL
    Transgenic Res; 2013 Oct; 22(5):949-64. PubMed ID: 23435752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.
    Jones SE; Schottstaedt MW; Duncan LA; Kirby RL; Good RH; Mennel RG; George TK; Snyder DA; Watkins DL; Denham CA; Hoyes FA; Rubin AS
    J Clin Oncol; 1996 Nov; 14(11):2976-83. PubMed ID: 8918495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GK-1 peptide reduces tumor growth, decreases metastatic burden, and increases survival in a murine breast cancer model.
    Torres-García D; Pérez-Torres A; Manoutcharian K; Orbe U; Servín-Blanco R; Fragoso G; Sciutto E
    Vaccine; 2017 Oct; 35(42):5653-5661. PubMed ID: 28890195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy.
    de Vries CR; Monken CE; Lattime EC
    Cancer Gene Ther; 2015 Apr; 22(3):154-62. PubMed ID: 25633483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.